Arisan Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch Arisan Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| ARN-75039 Lassa Fever Treatment in West Africa (NCT07419373) | Arisan Therapeutics, Inc. | 2026-02-14 |
| A Comparison of the Pharmacokinetic Properties of ARN-75039 Tablets With Excipients to Neat ARN-75039 in Hydroxypropyl Methylcellulose (HPMC) Capsules in Healthy Adult Participants Under Fed Conditions (NCT06911242) | Arisan Therapeutics, Inc. | 2025-02-27 |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects (NCT05735249) | Arisan Therapeutics, Inc. | 2023-01-23 |
Track Arisan Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.